2025-10-11 • praderwillinews.com
ARD-101 Phase 3 trial expands to PWS patients as young as 10
2025-10-11 • praderwillinews.com
ARD-101 Phase 3 trial expands to PWS patients as young as 102025-10-11 • eurekalert.org
The ISSCR launches roadmap for developing pluripotent stem cell-derived cellular therapies2025-10-11 • alsnewstoday.com
Pridopidine Phase 3 trial to start enrolling early next year2025-10-10 • neurologylive.com
Phase 3 BeeLine Trial to Evaluate Radiprodil in GRIN-Related Neurodevelopmental Disorder2025-10-10 • thebrighterside.news
New drug combination stops prostate cancer growth in phase 3 clinical trial2025-10-09 • biomedwire.com
Soligenix Inc. (NASDAQ: SNGX) Expands European Medical Advisory Board, Advances Phase 3 Study to Support HyBryte(TM) Development for CTCL2025-10-09 • manilatimes.net
Aardvark Therapeutics Announces FDA Alignment on Protocol Amendment Expanding Phase 3 HERO Trial Population for Prader-Willi Syndrome2025-10-09 • pharmiweb.com
Astria Therapeutics Initiates the Phase 3 ORBIT-EXPANSE Long-Term Trial of Navenibart in People with Hereditary Angioedema2025-10-09 • geneonline.com
Phase 3 Trial Shows Cagrilintide Monotherapy Leads to Weight Loss in Adults with Obesity2025-10-09 • globenewswire.com
Zenas BioPharma and InnoCare Pharma Announce License Agreement Granting Zenas Rights for Three Autoimmune Product Candidates, Including Orelabrutinib, a BTK Inhibitor in Phase 3 Development for Multiple Sclerosis2025-10-09 • globenewswire.com
Science 37 Completes Third FDA Inspection, Validating Quality of its Direct-to-Patient Site in Pivotal Phase 3 Rare Disease Trial2025-10-09 • clinicalleader.com
Expanding Accessibility In A Phase 3 Influenza Study Through Community-Based Research2025-10-09 • PR Newswire
Phase 3 Clinical Trial of HANSIZHUANG Plus Chemotherapy Meets Primary Endpoint in Neoadjuvant/Adjuvant Gastric Cancer, Greenlighting Early NDA Submission2025-10-08 • PR Newswire
Seasats Awarded $89M U.S. Navy SBIR Phase 3 IDIQ Contract, Building on Series of Operational Milestones2025-10-08 • PR Newswire
Karyopharm Announces Strategic Financing Transactions to Support Growth; Extends Cash Runway Into Second Quarter of 2026, Beyond Expected Top-Line Readout of Phase 3 SENTRY Trial in Myelofibrosis2025-10-07 • biomedwire.com
Soligenix Inc. (NASDAQ: SNGX) Reports Positive Safety Review from DMC in Ongoing Phase 3 FLASH2 Study of HyBryte for CTCL2025-10-07 • quiverquant.com
Invivyd Announces Upcoming Phase 3 Clinical Trials for VYD2311, a Novel COVID Prevention Therapy2025-10-07 • businesswire.com
Pridopidine Pivotal Phase 3 ALS Study Unveiled at NEALS 2025 Annual Meeting2025-10-07 • wtov9.com
Cameron nears completion of Phase 3 water project with new tanks and lines2025-10-07 • PR Newswire
Apnimed Announces Acceptance of Two Late-breaking Presentations and a Core Interactive Session at the CHEST Annual Meeting Highlighting New Positive AD109 Phase 3 Data and the Current Unmet Need in Obstructive Sleep Apnea2025-10-07 • PR Newswire
Soligenix Achieves Important Safety Milestone in its Confirmatory Phase 3 Clinical Trial of HyBryte™ for the Treatment of Cutaneous T-Cell Lymphoma2025-10-06 • simplywall.st
Harmony Biosciences (HRMY): Assessing Valuation After ZYN002 Phase 3 Setback in Fragile X Syndrome Study2025-10-06 • urologytimes.com
Glen Gejerman, MD, highlights phase 3 data on CAN-2409 in localized prostate cancer2025-10-03 • businesswireindia.com
Neuraptive Therapeutics, Inc. Announces First Patient Enrolled in Phase 3 Clinical Trial Evaluating the Safety and Efficacy of NTX-001 Compared to Standard of Care in the Treatment of Upper Extremity Transected Nerves Requiring Surgical Repair2025-10-03 • businesswire.com
Astria Therapeutics Now Enrolling HAE Patients in the European Union for the Phase 3 ALPHA-ORBIT Trial2025-10-03 • patientcareonline.com
Lipocine Updates Progress on Phase 3 Clinical Trial in Postpartum Depression with LPCN 11542025-10-03 • theaftd.org
Partners in FTD Care: Genetic FTD Trials Update – Approaching a Phase 3 Milestone2025-10-03 • medicaldialogues.in
SEC Recommends Phase III Trial Of MSN Labs' Vibegron Against Mirabegron In Overactive Bladder2025-10-03 • centerforbiosimilars.com
Proposed Aflibercept Biosimilar Shows Comparable Safety, Efficacy in Phase 3 AMD Trial2025-10-02 • PR Newswire
Landmark Phase 3 Trial (vesalius-cv) Meets Primary Endpoints in a Cardiovascular Primary Prevention Study of 12,000 Patients25 minutes ago • prnewswire.co.uk
The Bahamas Achieves Major Fiscal Progress, Strengthening its Position as a Stable and Sustainable Financial Partner2 hours ago • prnewswire.co.uk
Allergic Rhino-Conjunctivitis Market Poised for Significant Growth in the Coming 10 Years Amid Increasing Therapeutic Advancements | DelveInsight9 hours ago • fortuneindia.com
U.S. tariff hits Indian textile and apparel exporters; 50% drop in revenues, says survey9 hours ago • teslarati.com
xAI’s new facility will save Memphis 5 billion gallons of water annually9 hours ago • packaging-gateway.com
Amazon UAE introduces packaging recycling initiative across Dubai9 hours ago • hawaiinewsnow.com
10th LeaLea Charity Run proceeds to support Waikiki Aquarium9 hours ago • smallcaps.com.au
St George Mining’s Capital Raise for Araxá Project in Brazil Sees Big-Name Backing9 hours ago • marcamoney.com
Ekkaa Electronics raises ₹108 crore in Series A funding round9 hours ago • scmp.com
Hong Kong poised for greater role in Islamic finance, financial secretary says9 hours ago • cryptocurrencywire.com
Forward Industries, Inc. (NASDAQ: FORD) Extends Resale Registration Filing Amid Market Volatility, Reaffirms Long-Term Solana Strategy9 hours ago • defensewirenews.com
Datavault AI (NASDAQ: DVLT) Files Federal Lawsuit Alleging Market Manipulation, Defamation and Securities Fraud9 hours ago • missionir.com
Strawberry Fields REIT, Inc. (NYSE AMERICAN: STRW) to Present at LD Micro’s 19th Annual Main Event on Oct. 219 minutes ago • EIN Presswire
The Guardian Group, LLC Announces Psychiatrist Matthew Paley, DO, QME24 minutes ago • EIN Presswire
The 'Ethics Gap': 75% of Mediators Using AI Without Training as Professional Standards Lag Behind Technology25 minutes ago • PR Newswire
Tetra Technologies, Inc. Announces Third Quarter 2025 Earnings Release Conference Call and Webcast9 hours ago • moneycontrol.com
Jupiter Life Line in Rs 1,400-crore expansion push in Maharashtra, to double capacity by 20299 hours ago • indiantextilemagazine.in
Major Amendments to PLI Scheme, A Big Boost for MMF and Technical Textile Sectors9 hours ago • marcamoney.com
Ekkaa Electronics raises ₹108 crore in Series A funding round3 hours ago • EIN Presswire
Medical Fiber Optics Market Set to Boom to US$2.3 Billion by 2032 – Persistence Market Research3 hours ago • EIN Presswire
Vaginal Specula Market to Reach US$1.4 Billion by 2032, Growing at 3.9% CAGR – Persistence Market Research5 hours ago • EIN Presswire
Leading Europe Quadricycle Companies Renault, Aixam, and Ligier Positioned to Shape Market Expansion Through 2031Stay ahead with real-time headlines from top sources, categorized by sector and country.